Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v26-FR Version v22-FR
Language French French
Date Updated 2020-04-23 2020-02-07
Drug Identification Number 02441950 02441950
Brand name ACT METHYLPHENIDATE ER ACT METHYLPHENIDATE ER
Common or Proper name METHYLPHENIDATE METHYLPHENIDATE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 36MG 36MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-12-01 2018-12-01
Actual start date 2018-12-01 2018-12-01
Estimated end date 2020-08-31 2020-02-29
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Inventory will be managed and allocated for 100% of regular demand. Estimated run out will be late February. Previous EED of 04/30/20 was an entry error and has been corrected. Inventory will be managed and allocated for 100% of regular demand. Estimated run out will be late February.
Health Canada comments